About atai Life Sciences

Atai Life Sciences is a biotechnology company that develops therapies for mental health disorders. The company focuses on creating treatments using psychedelic compounds and other methods to address conditions such as depression, anxiety, and substance use disorders. Atai collaborates with various partners and research institutions to advance its drug development pipeline, which includes several clinical-stage programs. The product portfolio includes therapies that utilize research in psychedelics and neuroscience. Atai's lead programs feature ketamine-based treatments and other compounds aimed at improving mental well-being. The company works with experts in the field to ensure the efficacy and safety of its therapies. Atai Life Sciences has received recognition for its work in mental health treatment, securing partnerships and funding to support its research initiatives. The company has been acknowledged for its contributions to psychiatry and has gained attention for its efforts to advance the understanding and treatment of mental health disorders.

Investment Details

Investment Range
Not specified
Investment Stage
Various stages
Industry Focus
Biotechnology, AI/ML, Climate (+3 more)
Investor Type
Corporate Venture Capital

Investment Focus

Focus Areas
AI/ML Climate Healthcare IoT VR/AR +2 more
Investment Stages
Early Stage Venture, Late Stage Venture, Private Equity, Seed